相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting metabolic dysregulation for fibrosis therapy
Xiao Zhao et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
Boris Hinz et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Profibrotic Activation of Human Macrophages in Systemic Sclerosis
Rajan Bhandari et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Adipose-Derived Mesenchymal Stem Cells Modulate Fibrosis and Inflammation in the Peritoneal Fibrosis Model Developed in Uremic Rats
Elerson C. Costalonga et al.
STEM CELLS INTERNATIONAL (2020)
The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis
Thais Ribeiro Peclat et al.
CURRENT OPINION IN RHEUMATOLOGY (2020)
CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD+ and NMN levels
Claudia C. S. Chini et al.
NATURE METABOLISM (2020)
The Plasma NAD+ Metabolome Is Dysregulated in Normal Aging
James Clement et al.
REJUVENATION RESEARCH (2019)
A Machine Learning Classifier for Assigning Individual Patients With Systemic Sclerosis to Intrinsic Molecular Subsets
Jennifer M. Franks et al.
ARTHRITIS & RHEUMATOLOGY (2019)
The NADase CD38 is induced by factors secreted from senescent cells providing a potential link between senescence and age-related cellular NAD+ decline
Claudia Chini et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts
Mark A. Eckert et al.
NATURE (2019)
The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases
Kelly A. Hogan et al.
FRONTIERS IN IMMUNOLOGY (2019)
Nicotinamide riboside, an NAD plus precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis
Tho X. Pham et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Shared and distinct mechanisms of fibrosis
Joerg H. W. Distler et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Inhibition of CD38 with the Thiazoloquin(az)olin(on)e 78c Protects the Heart against Postischemic Injury
James Boslett et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Characterization of CD38 in the major cell types of the heart: endothelial cells highly express CD38 with activation by hypoxia-reoxygenation triggering NAD(P)H depletion
James Boslett et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2018)
A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline
Mariana G. Tarrago et al.
CELL METABOLISM (2018)
CD38-NAD(+)Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response
Shilpak Chatterjee et al.
CELL METABOLISM (2018)
NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
Jun Yoshino et al.
CELL METABOLISM (2018)
SFRP2/DPP4 and FMO1/LSP1 Define Major Fibroblast Populations in Human Skin
Tracy Tabib et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Genetic deletion of CD38 confers post-ischemic myocardial protection through preserved pyridine nucleotides
James Boslett et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging
Eduardo N. Chini et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Recent advances in mouse models for systemic sclerosis
Xiaoyang Yue et al.
AUTOIMMUNITY REVIEWS (2018)
TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung
Swati Bhattacharyya et al.
JCI INSIGHT (2018)
NAD and the aging process: Role in life, death and everything in between
Claudia C. S. Chini et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme
Pavlos Pissios
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)
Hepatic NAD+ deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing
Can-Can Zhou et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Loss of NAD Homeostasis Leads to Progressive and Reversible Degeneration of Skeletal Muscle
David W. Frederick et al.
CELL METABOLISM (2016)
CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism
Juliana Camacho-Pereira et al.
CELL METABOLISM (2016)
Animal models of scleroderma: recent progress
Roberta G. Marangoni et al.
CURRENT OPINION IN RHEUMATOLOGY (2016)
Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds
Michael S. Bonkowski et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation
Dongryeol Ryu et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Tenascin-C drives persistence of organ fibrosis
Swati Bhattacharyya et al.
NATURE COMMUNICATIONS (2016)
SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis
Kaname Akamata et al.
ONCOTARGET (2016)
Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics
Jennifer L. Sargent et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Sirt1 regulates canonical TGF-beta signalling to control fibroblast activation and tissue fibrosis
Pawel Zerr et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
The Kampo Medicine Daikenchuto Inhibits Peritoneal Fibrosis in Mice
Mineaki Kitamura et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus
Carles Canto et al.
CELL METABOLISM (2015)
Genetic Ablation of CD38 Protects against Western Diet-Induced Exercise Intolerance and Metabolic Inflexibility
Shian-Huey Chiang et al.
PLOS ONE (2015)
Depletion of NADP(H) due to CD38 activation triggers endothelial dysfunction in the postischemic heart
Levy A. Reyes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences
Xiao-Hong Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling
Jun Wei et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Systemic sclerosis
Yannick Allanore et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Revealing CD38 Cellular Localization Using a Cell Permeable, Mechanism-Based Fluorescent Small-Molecule Probe
Jonathan H. Shrimp et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Fibrosis-a lethal component of systemic sclerosis
Yuen Yee Ho et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
FibronectinEDA Promotes Chronic Cutaneous Fibrosis Through Toll-like Receptor Signaling
Swati Bhattacharyya et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging
Ana P. Gomes et al.
CELL (2013)
p300 Is Elevated in Systemic Sclerosis and Its Expression Is Positively Regulated by TGF-β: Epigenetic Feed-Forward Amplification of Fibrosis
Asish K. Ghosh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Recent Developments in Myofibroblast Biology Paradigms for Connective Tissue Remodeling
Boris Hinz et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
Swati Bhattacharyya et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Age-Associated Changes In Oxidative Stress and NAD+ Metabolism In Human Tissue
Hassina Massudi et al.
PLOS ONE (2012)
The Membrane-Bound Enzyme CD38 Exists in Two Opposing Orientations
Yong Juan Zhao et al.
SCIENCE SIGNALING (2012)
Sirtuins, Aging, and Medicine
Leonard Guarente
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Age Related Changes in NAD plus Metabolism Oxidative Stress and Sirt1 Activity in Wistar Rats (Publication with Expression of Concern. See vol. 17, 2022)
Nady Braidy et al.
PLOS ONE (2011)
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology
Fabio Malavasi et al.
PHYSIOLOGICAL REVIEWS (2008)
The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis
Asish K. Ghosh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity
Maria Thereza P. Barbosa et al.
FASEB JOURNAL (2007)
Systemic sclerosis: a prototypic multisystem fibrotic disorder
John Varga et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Regulation of SIRT 1 mediated NAD dependent deacetylation: A novel role for the multifunctional enzyme CD38
Pinar Aksoy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Regulation of intracellular levels of NAD: A novel role for CD38
Pinar Aksoy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Extra-dornain-a fibronectin: A new marker of fibrosis in cutaneous Graft-Versus-Host disease
HM van der Straaten et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor β responses in skin fibroblasts
Y Mori et al.
ARTHRITIS AND RHEUMATISM (2004)
A novel mechanism for coupling cellular intermediary metabolism to cytosolic Ca2+ signaling via CD38/ADP-ribosyl cyclase, a putative intracellular NAD(+) sensor
L Sun et al.
FASEB JOURNAL (2002)
分享论文
